14% increase in coffee pounds processed and sold in fiscal 2014 versus fiscal 2013
Net income in fiscal 2014 was $12.1 million versus net loss of $8.5 million in fiscal 2013
Adjusted EBITDA in fiscal 2014 was $46.1 million versus $28.7 million in fiscal 2013
Effective pay-down of credit facility from $19.7 million at the end of fiscal 2013 to $78,000 at the end of fiscal 2014
TORRANCE, Calif., Sept.
MENLO PARK, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq:LNDC) , a Company that develops and markets innovative and proprietary products for healthy living applications in food and biomedical markets, reported results for the fiscal 2014 fourth quarter and fiscal year ended May 25, 2014.
Patterson Companies, Inc. (Nasdaq: PDCO) today reported that
consolidated sales totaled $1,059.5 million in its fiscal first quarter,
ended July 26, 2014, an increase of more than 20 percent from $880.1
million in the year-earlier period.
Senesco Technologies, Inc. doing business as Sevion Therapeutics
("Sevion" or the "Company") (OTCQB:SNTI) today reported financial
results for the fiscal year ended June 30, 2014 (“Fiscal 2014”), and
also provided an overview of corporate accomplishments and plans.
HONG KONG, June 30, 2014 (GLOBE NEWSWIRE) -- Highway Holdings Limited (Nasdaq:HIHO) today reported results for its fourth quarter and fiscal year ended March 31, 2014, reflecting a sharp increase in profitability on a year-over-year basis and solid operational strength for the quarter and full year.
~ Urgent PC Sales Up 19% in Fiscal First Quarter ~~Fiscal 2015 Guidance Reaffirmed MINNEAPOLIS , July 24, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) , a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 first quarter ended June 30, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.